RVFV Cell Signaling 27. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: Downstream AKTion Blocks Apoptosis Cell 88: 435–437. 28. Burgering BM, Coffer PJ (1995) Proteine kinase B (c-AKT) in phosphatidyli- nositol-3-OH kinase signaling transduction. Nature 376: 599–602. 29. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, et al. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF- activated phosphatidylinositol 3-kinase. Cell 81: 727–736. 30. Altieri DC, Marchisio PC (1999) Surviving apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79: 1327–1333. 31. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, et al. (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796–803. 32. Kasof GM, Gomes BC (2001) Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 276: 3238–46. 33. Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell death proteases. Nature 388: 300–304. 34. Ji WT, Liu HJ (2008) PI3K-Akt signaling and viral infection. Recent Pat Biotechnol 2: 218–26. 35. Eckelmam, Salvesen GS, Scott FL (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7: 988–994. 36. Cain K, Bratton SB, Cohen GM (2002) The Apaf-1 apoptosome: a large caspase–activating complex. Biochimie 84: 203–214. 37. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, et al. (2000) Alpha/beta interferons potentiate virus-induced apoptosis through activation of FADD/Caspase-8 death signaling pathway. J Virol 74: 1513–1523. 38. Wurzer WJ, Planz O, Ehrhardt C, Giner M, Silberzahn T, et al. (2003) Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 22: 2717–28. 39. Sandhu KS, Al-Rubeai M (2009) The effect of Bcl-2, YAMA, and XIAP over- expression on apoptosis and adenovirus production in HEK293 cell line. Biotechnol Bioeng 104: 752–765. 40. Olsson A, Manzl C, Strasser A, Villunger A (2007) How important are post- translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death and Differentiation 14: 1561–1575. 41. Ballif BA, Blenis J (2001) Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12: 397–408. 42. Rubinfeld H, Seger R (2005) The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol 31: 151–174. 43. Meloche S, Pouyssegur J (2007) The ERK1/2 mitogenactivated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227–3239. 44. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, et al. (2001) Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signaling cascade. Nat Cell Biol 3: 301–305. PLoS ONE | www.plosone.org 13 November 2010 | Volume 5 | Issue 11 | e13805